FDAScienceCases Among Kids, New Mandates, and More Coronavirus NewsBy Eve SneiderThe Big StoryHow Fringe Stem Cell Treatments Won Allies on the Far RightBy Lindsay GellmanScienceA Vaccine Can Be Bad for a Person but Awesome for All PeopleBy Adam RogersScienceA Pause on J&J, Preparation for Booster Shots, and More NewsBy Elena LaceyIdeasThe FDA’s Decision to Pause J&J Could Help Defeat Covid-19By Zoë McLarenBusinessThis AI Could Help Wipe Out Colon CancerBy Sara HarrisonScienceA Shot Nears Approval, Experts Study Transmission, and MoreBy Eve SneiderIdeasThe AstraZeneca Covid Vaccine Data Isn't Up to SnuffBy Hilda BastianScienceWe’ll Need More Than One Vaccine to Beat the PandemicBy Adam RogersIdeasMore Safety Data Would Be Nice, But We Need a Vaccine NowBy Walid GelladThe Big StoryPrevagen Made Millions—as the FDA Questioned Its SafetyBy Chiara EisnerIdeasTrump’s ‘Miracle Cure’ for Covid Is a Logistical NightmareBy Walid GelladIdeasLet’s Get Real About the President’s Antibody TreatmentBy Hilda BastianScienceThe 943-Dimensional Chess of a Trustworthy Covid-19 VaccineBy Adam RogersIdeasDon't Yell About a Rushed Vaccine—Just Plan for ItBy Walid GelladIdeasNo, Public Trust in Scientific Institutions Has Not ErodedBy Daniel EngberIdeasThe FDA's Approach to Covid-19 Is a Bloody MessBy Hilda BastianScienceThe End Is Nearer for ‘Forever Chemicals’ in Food WrappersBy Michele Cohen MarillScienceFDA Revokes Hydroxychloroquine's Emergency Use AuthorizationBy Grace HuckinsScienceThe FDA Asks Companies to Stop Selling RanitidineBy Michele Cohen MarillBusinessJewelry. Candles. Hand Sanitizer. Welcome to Coronavirus EtsyBy Arielle PardesCultureRelease the Kratom: Inside America's Hottest New Drug CultureBy Emma Grey EllisScienceThe FDA Announces Two More Antacid Recalls Due to Cancer RiskBy Michele Cohen MarillBusinessJuul, Under Heavy Fire, Pulls Fruit-Flavored Pods From USBy Sara HarrisonMore Stories
